Population
Discoidal phospholipid complexes prepared with apoC-III and di[C]palmitoyl phosphatidylcholine, and guinea…
Comparison
Presence of apolipoprotein C-II (apoC-II) vs Absence of apolipoprotein C-II
Design
Preclinical
Authors
Loading...
Should not change clinical lipid management; leaves open ApoC-II as LpL regulator pending human validation.
Apolipoprotein C-II enhances phospholipid hydrolysis by lipoprotein lipase primarily by increasing the maximal velocity (Vmax) for the substrates, while decreasing the apparent Km for triacylglycerol hydrolysis.
Shirai et al. (1983) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: